These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32281569)

  • 41. [A Successful Case of Locally Advanced Pancreatic Cancer Undergoing Curative Total Pancreatectomy after Chemotherapy].
    Terashima T; Kawamoto S; Maekawa K; Shinozaki N; Kuroki N
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):688-690. PubMed ID: 32389985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The value of extended surgery for pancreatic cancer in the context of neoadjuvant therapy].
    Zhang TP; Liu YZ; Cao Z
    Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):481-485. PubMed ID: 32610414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation.
    Hoffe S; Rao N; Shridhar R
    Semin Radiat Oncol; 2014 Apr; 24(2):113-25. PubMed ID: 24635868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta-analysis.
    Rangarajan K; Pucher PH; Armstrong T; Bateman A; Hamady Z
    Ann R Coll Surg Engl; 2019 Sep; 101(7):453-462. PubMed ID: 31304767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Call for better response evaluation after neoadjuvant therapy in pancreatic cancer.
    Zaharia C; Søreide K
    Br J Surg; 2023 Feb; 110(3):294-296. PubMed ID: 36630676
    [No Abstract]   [Full Text] [Related]  

  • 46. [Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma].
    Motoi F; Kawaguchi K; Aoki T; Kudo K; Yabuuchi S; Fukase K; Mizuma M; Sakata N; Otsutomo S; Morikawa T; Hayashi H; Nakagawa K; Okada T; Yoshida H; Naitoh T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1632-6. PubMed ID: 24393872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined-modality treatment for operable pancreatic adenocarcinoma.
    Pisters PW; Wolff RA; Crane CH; Evans DB
    Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Status of neoadjuvant therapy for resectable pancreatic cancer.
    Hoffman JP
    Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoadjuvant chemo(radio)therapy in upfront resectable pancreatic cancer - can we stratify patients better in the future?
    Andersson R; Tingstedt B
    Scand J Gastroenterol; 2023 Jan; 58(1):1-2. PubMed ID: 35856841
    [No Abstract]   [Full Text] [Related]  

  • 50. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current consensus and controversy in neoadjuvant therapy for pancreatic cancer].
    Ou ZL; Li YX; Ji LD; Ke MJ
    Zhonghua Wai Ke Za Zhi; 2020 Feb; 58(2):99-104. PubMed ID: 32074807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Still no evidence for neoadjuvant therapy of pancreatic cancer].
    Strobel O; Büchler MW
    Chirurg; 2020 Jul; 91(7):596. PubMed ID: 32500215
    [No Abstract]   [Full Text] [Related]  

  • 54. Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.
    Heinrich S; Lang H
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatoblastoma: A rare indication for liver transplantation in children.
    Mercadal-Hally M; Vaidya S; Vilca-Melendez H; Heaton N; Dhawan A; Grammatikopoulos T
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):499-501. PubMed ID: 32736920
    [No Abstract]   [Full Text] [Related]  

  • 56. Preoperative chemoradiation therapy for pancreatic cancer.
    Evans DB; Pisters PW
    Surg Clin North Am; 2001 Jun; 81(3):709-13. PubMed ID: 11459284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis.
    Choi JG; Nipp RD; Tramontano A; Ali A; Zhan T; Pandharipande P; Dowling EC; Ferrone CR; Hong TS; Schrag D; Fernandez-Del Castillo C; Ryan DP; Kong CY; Hur C
    Oncologist; 2019 Jul; 24(7):945-954. PubMed ID: 30559125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How to define and manage borderline resectable pancreatic cancer.
    Papavasiliou P; Chun YS; Hoffman JP
    Surg Clin North Am; 2013 Jun; 93(3):663-74. PubMed ID: 23632151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
    Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
    Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer.
    Goff SL; Chabot JA
    Cancer J; 2012; 18(6):602-8. PubMed ID: 23187848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.